iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
80.91%
Change (1 year)
Categories
iBio (IBIO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $24.82 M
According to iBio's latest financial reports the company's total liabilities are $24.82 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
iBio - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $25.82 M | -28.1% |
| 2022-06-30 | $35.92 M | -6.46% |
| 2021-06-30 | $38.4 M | 2.18% |
| 2020-06-30 | $37.58 M | 33.61% |
| 2019-06-30 | $28.12 M | 4.49% |
| 2018-06-30 | $26.91 M | -0.65% |
| 2017-06-30 | $27.09 M | -1.67% |
| 2016-06-30 | $27.55 M | 2081.79% |
| 2015-06-30 | $1.26 M | 219.75% |
| 2014-06-30 | $0.39 M | -90.78% |
| 2013-06-30 | $4.28 M | 19.19% |
| 2012-06-30 | $3.59 M | -49.63% |
| 2011-06-30 | $7.13 M | 85.24% |
| 2010-06-30 | $3.85 M | 610.91% |
| 2009-06-30 | $0.54 M | -94.44% |
| 2008-06-30 | $9.75 M | 20.37% |
| 2007-06-30 | $8.1 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 397,821.45% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | $26.4 M | 6.36% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | $0.26 B | 975.71% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.17 B | 4,628.70% | 🇺🇸 USA |